Cargando…

Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA

Mitochondria, the energy stations of the cell, are the only extranuclear organelles, containing their own (mitochondrial) DNA (mtDNA) and the protein synthesizing machinery. The location of mtDNA in close proximity to the oxidative phosphorylation system of the inner mitochondrial membrane, the main...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buneeva, Olga, Fedchenko, Valerii, Kopylov, Arthur, Medvedev, Alexei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763033/ https://www.ncbi.nlm.nih.gov/pubmed/33321831 http://dx.doi.org/10.3390/biomedicines8120591

Ejemplares similares

Renalase mRNA levels in the brain, heart, and kidneys of spontaneously hypertensive rats with moderate and high hypertension
por: Fedchenko, Valerii, et al.
Publicado: (2013)

Proteomic profiling data of HEK293 proteins bound to human recombinant renalases-1 and -2
por: Fedchenko, Valerii I., et al.
Publicado: (2018)

The Effect of Neurotoxin MPTP and Neuroprotector Isatin on the Profile of Ubiquitinated Brain Mitochondrial Proteins
por: Buneeva, Olga, et al.
Publicado: (2018)

Atypical Ubiquitination and Parkinson’s Disease
por: Buneeva, Olga, et al.
Publicado: (2022)

Use of Biotinylated Ubiquitin for Analysis of Rat Brain Mitochondrial Proteome and Interactome
por: Buneeva, Olga A., et al.
Publicado: (2012)

Construction of the Coding Sequence of the Transcription Variant 2 of the Human Renalase Gene and Its Expression in the Prokaryotic System
por: Fedchenko, Valerii I., et al.
Publicado: (2013)

Tryptophan Metabolites as Mediators of Microbiota-Gut-Brain Communication: Focus on Isatin
por: Medvedev, Alexei, et al.
Publicado: (2022)

20S and 26S proteasome-binding proteins of the rabbit brain: A proteomic dataset
por: Buneeva, Olga, et al.
Publicado: (2021)

A Neuroprotective Dose of Isatin Causes Multilevel Changes Involving the Brain Proteome: Prospects for Further Research
por: Medvedev, Alexei, et al.
Publicado: (2020)

Biological targets for isatin and its analogues: Implications for therapy
por: Medvedev, Alexei, et al.
Publicado: (2007)

Mitochondrial dysfunction in Parkinson’s disease
por: Hu, Qingsong, et al.
Publicado: (2016)

Mitochondrial Dysfunction in Parkinson's Disease
por: Keane, P. C., et al.
Publicado: (2011)

Mitochondrial Dysfunction in Parkinson's Disease
por: Moon, Hyo Eun, et al.
Publicado: (2015)

Proteomic Profiling of Mouse Brain Pyruvate Kinase Binding Proteins: A Hint for Moonlighting Functions of PKM1?
por: Buneeva, Olga, et al.
Publicado: (2023)

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
por: Larsen, S. B., et al.
Publicado: (2018)

Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence?
por: Chen, Chun, et al.
Publicado: (2019)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson’s Disease
por: Bajracharya, Rijan, et al.
Publicado: (2019)

Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
por: Prasuhn, Jannik, et al.
Publicado: (2021)

The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson’s disease
por: Chen, Zixuan, et al.
Publicado: (2021)

Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with Pathophysiology
por: Pizarro-Galleguillos, Benjamin Matís, et al.
Publicado: (2023)

The Effects of Endogenous Non-Peptide Molecule Isatin and Hydrogen Peroxide on Proteomic Profiling of Rat Brain Amyloid-β Binding Proteins: Relevance to Alzheimer’s Disease?
por: Medvedev, Alexei E., et al.
Publicado: (2014)

Disulfiram Oxy-Derivatives Suppress Protein Retrotranslocation across the ER Membrane to the Cytosol and Initiate Paraptosis-like Cell Death
por: Solovieva, Marina, et al.
Publicado: (2022)

Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress
por: Jurcau, Anamaria
Publicado: (2021)

Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease: The Emerging Role of VDAC
por: Risiglione, Pierpaolo, et al.
Publicado: (2021)

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
por: Henrich, Martin T., et al.
Publicado: (2023)

Mitochondrial biology and dysfunction in secondary mitochondrial disease
por: Baker, Megan J., et al.
Publicado: (2022)

αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?
por: Protter, David, et al.
Publicado: (2012)

Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease
por: Olagunju, Abolaji Samson, et al.
Publicado: (2023)

The implication of mitochondrial DNA mutation and dysfunction in periodontal diseases
por: Kannan, Balachander, et al.
Publicado: (2023)

Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease
por: Kung, Heng-Chung, et al.
Publicado: (2021)

Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson’s Disease: Roads to Biomarker Discovery
por: Picca, Anna, et al.
Publicado: (2021)

Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
por: Pizarro-Galleguillos, Benjamin Matis, et al.
Publicado: (2022)

Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease
por: Lee, Hoyul, et al.
Publicado: (2023)

Brain Mitochondrial Dysfunction in Aging, Neurodegeneration, and Parkinson's Disease
por: Navarro, Ana, et al.
Publicado: (2010)

Synergistic Effect of Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease
por: Guerra, Flora, et al.
Publicado: (2019)

Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
por: Bantle, Collin M., et al.
Publicado: (2021)

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease
por: Ganguly, Gargi, et al.
Publicado: (2017)

Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's Disease?
por: Clark, Joanne, et al.
Publicado: (2011)

Mitochondrial Dysfunction Associated with mtDNA in Metabolic Syndrome and Obesity
por: Todosenko, Natalia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_op40fjfacaj2rurk9l27vkv7fl